Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 14

1.

Vibrio cholerae O139 Bengal.

Albert MJ.

J Clin Microbiol. 1994 Oct;32(10):2345-9. Review. No abstract available.

2.

Cholera.

Kaper JB, Morris JG Jr, Levine MM.

Clin Microbiol Rev. 1995 Jan;8(1):48-86. Review. Erratum in: Clin Microbiol Rev 1995 Apr;8(2):316.

3.

Molecular characterization of environmental and nontoxigenic strains of Vibrio cholerae.

Kaper JB, Moseley SL, Falkow S.

Infect Immun. 1981 May;32(2):661-7.

4.

Diseases of humans (other than cholera) caused by vibrios.

Blake PA, Weaver RE, Hollis DG.

Annu Rev Microbiol. 1980;34:341-67. Review. No abstract available.

PMID:
7002028
5.

New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Levine MM, Kaper JB, Black RE, Clements ML.

Microbiol Rev. 1983 Dec;47(4):510-50. Review.

6.

Immunological differences among the cholera/coli family of enterotoxins.

Marchlewicz BA, Finkelstein RA.

Diagn Microbiol Infect Dis. 1983 Jun;1(2):129-38.

PMID:
6201315
7.

Cholera and other vibrioses in the United States.

Morris JG Jr, Black RE.

N Engl J Med. 1985 Feb 7;312(6):343-50. Review. No abstract available.

PMID:
3881668
8.

Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein.

Miller VL, Taylor RK, Mekalanos JJ.

Cell. 1987 Jan 30;48(2):271-9.

PMID:
3802195
9.

Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.

Levine MM, Kaper JB, Herrington D, Losonsky G, Morris JG, Clements ML, Black RE, Tall B, Hall R.

Infect Immun. 1988 Jan;56(1):161-7.

10.

Epidemiology and spectrum of Vibrio infections in a Chesapeake Bay community.

Hoge CW, Watsky D, Peeler RN, Libonati JP, Israel E, Morris JG Jr.

J Infect Dis. 1989 Dec;160(6):985-93.

PMID:
2584765
11.

Role of prostaglandins and cAMP in the secretory effects of cholera toxin.

Peterson JW, Ochoa LG.

Science. 1989 Aug 25;245(4920):857-9.

PMID:
2549637
12.

Epitopes of the cholera family of enterotoxins.

Finkelstein RA, Burks MF, Zupan A, Dallas WS, Jacob CO, Ludwig DS.

Rev Infect Dis. 1987 May-Jun;9(3):544-61.

PMID:
2440089
13.

Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.

Clemens JD, Sack DA, Harris JR, Van Loon F, Chakraborty J, Ahmed F, Rao MR, Khan MR, Yunus M, Huda N, et al.

Lancet. 1990 Feb 3;335(8684):270-3.

PMID:
1967730
14.

Activation of adenylate cyclase by choleragen.

Moss J, Vaughan M.

Annu Rev Biochem. 1979;48:581-600. Review. No abstract available.

PMID:
224804

Supplemental Content

Support Center